Skip to main content
FinSpry Logo
FinSpry
ALNY logo
ALNY
(NASDAQ)
Alnylam Pharmaceuticals, Inc.
$298.48-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Alnylam Pharmaceuticals (ALNY) Stock Price & Financial Analysis

Alnylam Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$292.10 - $300.08
52-Week High$495.55
52-Week Low$261.45
Open$297.80
Volume797.65K
Average Volume (3M)1.10M
Market Cap39.57B
Shares Outstanding138.23M
P/E Ratio (TTM)68.72
Price to Sales (P/S)9.25
Price to Book (P/B)36.89
EV/EBITDA42.15
Revenue (TTM)4.29B
Net Income (TTM)577.22M
Free Cash Flow (TTM)643.34M
EPS (TTM)$4.26
Profit Margin13.46%
Operating Margin17.54%
Return on Equity (ROE)53.68%
Debt to Equity0.94
50-Day MA$314.75
200-Day MA$391.88
52-Week Change5.42%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Alnylam Pharmaceuticals

What is the current stock price for ALNY?

As of the latest trading session, ALNY stock trades at $298.48. The 52-week range is $261.45–$495.55, with a day range of $292.10–$300.08.

What is the P/E ratio for ALNY?

Alnylam Pharmaceuticals's trailing P/E ratio is 68.7, meaning investors pay $68.7 for every $1 of annual earnings.

Does ALNY pay dividends?

Alnylam Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ALNY?

Based on 14 analysts, the consensus for ALNY is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ALNY?

Alnylam Pharmaceuticals's market capitalization is $41.26B, classifying it as a large-cap company..